Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allan D Struthers

Showing results (151-160 of 165) with videos related to

Pageof 17
Sort By:
Lancet (London, England)|October 14, 2022
Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trialIsla S Mackenzie, Amy Rogers, Neil R Poulter, et al.
Radiology|May 2, 2018
Prevalence and Distribution of Atherosclerosis in a Low- to Intermediate-Risk Population: Assessment with Whole-Body MR AngiographyMatthew A Lambert, Jonathan R Weir-McCall, Marco Salsano, et al.
Journal of the American College of Cardiology|November 19, 2016
Left Ventricular Noncompaction: Anatomical Phenotype or Distinct Cardiomyopathy?Jonathan R Weir-McCall, Phey Ming Yeap, Carla Papagiorcopulo, et al.
European Heart Journal. Cardiovascular Imaging|August 24, 2016
Prevalence of unrecognized myocardial infarction in a low-intermediate risk asymptomatic cohort and its relation to systemic atherosclerosisJonathan R Weir-McCall, Kerrie Fitzgerald, Carla J Papagiorcopulo, et al.
Health Technology Assessment (Winchester, England)|March 29, 2024
Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease: the ALL-HEART RCT and economic evaluationIsla S Mackenzie, Christopher J Hawkey, Ian Ford, et al.
Lancet (London, England)|October 10, 2022
Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trialIsla S Mackenzie, Christopher J Hawkey, Ian Ford, et al.
Hypertension (Dallas, Tex. : 1979)|March 21, 2018
Development and Validation of a Path Length Calculation for Carotid-Femoral Pulse Wave Velocity Measurement: A TASCFORCE, SUMMIT, and Caerphilly Collaborative VentureJonathan R Weir-McCall, Liam Brown, Jennifer Summersgill, et al.
Journal of the American Society of Nephrology : JASN|August 21, 2020
Vitamin K Supplementation to Improve Vascular Stiffness in CKD: The K4Kidneys Randomized Controlled TrialMiles D Witham, Jennifer S Lees, Myra White, et al.
JAMA Internal Medicine|March 17, 2015
Effect of Vitamin D Supplementation on Blood Pressure: A Systematic Review and Meta-analysis Incorporating Individual Patient DataLouise A Beveridge, Allan D Struthers, Faisel Khan, et al.
Journal of the American Heart Association|June 1, 2018
Effect of Vitamin D Supplementation on Markers of Vascular Function: A Systematic Review and Individual Participant Meta-AnalysisLouise A Beveridge, Faisel Khan, Allan D Struthers, et al.
Pageof 17

Showing results (151-160 of 165) with videos related to

Sort By:
Pageof 17
Lancet (London, England)|October 14, 2022
Cardiovascular outcomes in adults with hypertension with evening versus morning dosing of usual antihypertensives in the UK (TIME study): a prospective, randomised, open-label, blinded-endpoint clinical trialIsla S Mackenzie, Amy Rogers, Neil R Poulter, et al.
Radiology|May 2, 2018
Prevalence and Distribution of Atherosclerosis in a Low- to Intermediate-Risk Population: Assessment with Whole-Body MR AngiographyMatthew A Lambert, Jonathan R Weir-McCall, Marco Salsano, et al.
Journal of the American College of Cardiology|November 19, 2016
Left Ventricular Noncompaction: Anatomical Phenotype or Distinct Cardiomyopathy?Jonathan R Weir-McCall, Phey Ming Yeap, Carla Papagiorcopulo, et al.
European Heart Journal. Cardiovascular Imaging|August 24, 2016
Prevalence of unrecognized myocardial infarction in a low-intermediate risk asymptomatic cohort and its relation to systemic atherosclerosisJonathan R Weir-McCall, Kerrie Fitzgerald, Carla J Papagiorcopulo, et al.
Health Technology Assessment (Winchester, England)|March 29, 2024
Allopurinol and cardiovascular outcomes in patients with ischaemic heart disease: the ALL-HEART RCT and economic evaluationIsla S Mackenzie, Christopher J Hawkey, Ian Ford, et al.
Lancet (London, England)|October 10, 2022
Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, open-label, blinded-endpoint trialIsla S Mackenzie, Christopher J Hawkey, Ian Ford, et al.
Hypertension (Dallas, Tex. : 1979)|March 21, 2018
Development and Validation of a Path Length Calculation for Carotid-Femoral Pulse Wave Velocity Measurement: A TASCFORCE, SUMMIT, and Caerphilly Collaborative VentureJonathan R Weir-McCall, Liam Brown, Jennifer Summersgill, et al.
Journal of the American Society of Nephrology : JASN|August 21, 2020
Vitamin K Supplementation to Improve Vascular Stiffness in CKD: The K4Kidneys Randomized Controlled TrialMiles D Witham, Jennifer S Lees, Myra White, et al.
JAMA Internal Medicine|March 17, 2015
Effect of Vitamin D Supplementation on Blood Pressure: A Systematic Review and Meta-analysis Incorporating Individual Patient DataLouise A Beveridge, Allan D Struthers, Faisel Khan, et al.
Journal of the American Heart Association|June 1, 2018
Effect of Vitamin D Supplementation on Markers of Vascular Function: A Systematic Review and Individual Participant Meta-AnalysisLouise A Beveridge, Faisel Khan, Allan D Struthers, et al.
Pageof 17